EP 1853595 A1 20071114 - (1,5-DIPHENYL-1H-PYRAZOL-3-YL)OXADIAZOLE DERIVATIVES, PREPARATION METHOD THEREOF AND USE OF SAME IN THERAPEUTICS
Title (en)
(1,5-DIPHENYL-1H-PYRAZOL-3-YL)OXADIAZOLE DERIVATIVES, PREPARATION METHOD THEREOF AND USE OF SAME IN THERAPEUTICS
Title (de)
(1,5-DIPHENYL-1H-PYRAZOL-3-YL)OXADIAZOLDERIVATE, VERFAHREN ZU DEREN HERSTELLUNG UND DEREN VERWENDUNG IN THERAPEUTIKA
Title (fr)
DERIVES DE (1,5-DIPHENYL-1H-PYRAZOL-3-YL)OXADIAZOLE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
Publication
Application
Priority
- FR 2006000368 W 20060217
- FR 0501860 A 20050221
Abstract (en)
[origin: WO2006087480A1] The invention relates to compounds having formula (I), wherein: R<SUB>1</SUB> represents a heterocylic radical selected from among formula (II), R<SUB>2</SUB> represents a (C<SUB>1</SUB>-C<SUB>5</SUB>)alkyl or a cyano, R<SUB>3</SUB> represents a substituted or non-substituted phenyl, and R<SUB>4</SUB> represents a substituted or non-substituted phenyl, as well as to the hydrates or solvates thereof.
IPC 8 full level
C07D 413/04 (2006.01); A61K 31/415 (2006.01); A61K 31/4155 (2006.01); A61P 1/00 (2006.01); C07D 231/04 (2006.01)
CPC (source: EP KR US)
A61K 31/4245 (2013.01 - KR); A61P 1/00 (2017.12 - EP); A61P 1/04 (2017.12 - EP); A61P 1/08 (2017.12 - EP); A61P 1/12 (2017.12 - EP); A61P 1/14 (2017.12 - EP); A61P 1/16 (2017.12 - EP); A61P 3/04 (2017.12 - EP); A61P 3/10 (2017.12 - EP); A61P 5/00 (2017.12 - EP); A61P 7/00 (2017.12 - EP); A61P 9/08 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 9/14 (2017.12 - EP); A61P 11/06 (2017.12 - EP); A61P 13/02 (2017.12 - EP); A61P 13/10 (2017.12 - EP); A61P 15/10 (2017.12 - EP); A61P 15/12 (2017.12 - EP); A61P 19/02 (2017.12 - EP); A61P 19/10 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/04 (2017.12 - EP); A61P 25/06 (2017.12 - EP); A61P 25/08 (2017.12 - EP); A61P 25/14 (2017.12 - EP); A61P 25/18 (2017.12 - EP); A61P 25/20 (2017.12 - EP); A61P 25/22 (2017.12 - EP); A61P 25/24 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 25/32 (2017.12 - EP); A61P 25/34 (2017.12 - EP); A61P 27/06 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 31/00 (2017.12 - EP); A61P 31/12 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 37/02 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07D 413/04 (2013.01 - EP KR US)
Citation (search report)
See references of WO 2006087480A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK YU
DOCDB simple family (publication)
FR 2882365 A1 20060825; FR 2882365 B1 20070907; AR 055560 A1 20070822; AU 2006215443 A1 20060824; BR PI0606845 A2 20090721; CA 2597359 A1 20060824; CN 101119990 A 20080206; DO P2006000045 A 20061115; EA 200701779 A1 20080228; EP 1853595 A1 20071114; GT 200600082 A 20061019; IL 185163 A0 20071203; JP 2008530188 A 20080807; JP 4812778 B2 20111109; KR 20070107053 A 20071106; MA 29261 B1 20080201; MX 2007009994 A 20071010; NO 20074763 L 20071116; NZ 560790 A 20090828; PA 8663901 A1 20061207; PE 20061038 A1 20061124; SV 2007002422 A 20070117; TW 200640916 A 20061201; US 2008039510 A1 20080214; US 7632852 B2 20091215; UY 29388 A1 20061002; WO 2006087480 A1 20060824; ZA 200706953 B 20090325
DOCDB simple family (application)
FR 0501860 A 20050221; AR P060100610 A 20060221; AU 2006215443 A 20060217; BR PI0606845 A 20060217; CA 2597359 A 20060217; CN 200680004984 A 20060217; DO 2006000045 A 20060220; EA 200701779 A 20060217; EP 06709338 A 20060217; FR 2006000368 W 20060217; GT 200600082 A 20060220; IL 18516307 A 20070809; JP 2007555667 A 20060217; KR 20077019014 A 20070820; MA 30157 A 20070823; MX 2007009994 A 20060217; NO 20074763 A 20070918; NZ 56079006 A 20060217; PA 8663901 A 20060221; PE 2006000202 A 20060217; SV 2006002422 A 20060221; TW 95105632 A 20060220; US 83567007 A 20070808; UY 29388 A 20060221; ZA 200706953 A 20060217